Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Goette

Showing results (161-170 of 194) with videos related to

Pageof 20
Sort By:
Lancet (London, England)|September 4, 2016
Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trialAndreas Goette, Jose L Merino, Michael D Ezekowitz, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 15, 2019
'Real-world' observational studies in arrhythmia research: data sources, methodology, and interpretation. A position document from European Heart Rhythm Association (EHRA), endorsed by Heart Rhythm Society (HRS), Asia-Pacific HRS (APHRS), and Latin America HRS (LAHRS)Christian Torp-Pedersen, Andreas Goette, Peter Bronnum Nielsen, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 28, 2007
Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm AssociationPaulus Kirchhof, Angelo Auricchio, Jeroen Bax, et al.
Circulation|July 30, 2021
Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart FailureAndreas Rillig, Christina Magnussen, Ann-Kathrin Ozga, et al.
European Heart Journal|September 28, 2007
Outcome parameters for trials in atrial fibrillation: executive summaryPaulus Kirchhof, Angelo Auricchio, Jeroen Bax, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 4, 2024
Safety and efficacy of long-term sodium channel blocker therapy for early rhythm control: the EAST-AFNET 4 trialAndreas Rillig, Lars Eckardt, Katrin Borof, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 6, 2016
The wearable cardioverter-defibrillator: current technology and evolving indicationsSven Reek, Haran Burri, Paul R Roberts, et al.
European Heart Journal|August 27, 2021
Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trialStephan Willems, Katrin Borof, Axel Brandes, et al.
Journal of the American Heart Association|November 20, 2023
Heart Failure, Female Sex, and Atrial Fibrillation Are the Main Drivers of Human Atrial Cardiomyopathy: Results From the CATCH ME ConsortiumJoris Winters, Aaron Isaacs, Stef Zeemering, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 2, 2021
Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST - AFNET 4 trialAndreas Metzner, Anna Suling, Axel Brandes, et al.
Pageof 20

Showing results (161-170 of 194) with videos related to

Sort By:
Pageof 20
Lancet (London, England)|September 4, 2016
Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trialAndreas Goette, Jose L Merino, Michael D Ezekowitz, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 15, 2019
'Real-world' observational studies in arrhythmia research: data sources, methodology, and interpretation. A position document from European Heart Rhythm Association (EHRA), endorsed by Heart Rhythm Society (HRS), Asia-Pacific HRS (APHRS), and Latin America HRS (LAHRS)Christian Torp-Pedersen, Andreas Goette, Peter Bronnum Nielsen, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 28, 2007
Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm AssociationPaulus Kirchhof, Angelo Auricchio, Jeroen Bax, et al.
Circulation|July 30, 2021
Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart FailureAndreas Rillig, Christina Magnussen, Ann-Kathrin Ozga, et al.
European Heart Journal|September 28, 2007
Outcome parameters for trials in atrial fibrillation: executive summaryPaulus Kirchhof, Angelo Auricchio, Jeroen Bax, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 4, 2024
Safety and efficacy of long-term sodium channel blocker therapy for early rhythm control: the EAST-AFNET 4 trialAndreas Rillig, Lars Eckardt, Katrin Borof, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 6, 2016
The wearable cardioverter-defibrillator: current technology and evolving indicationsSven Reek, Haran Burri, Paul R Roberts, et al.
European Heart Journal|August 27, 2021
Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trialStephan Willems, Katrin Borof, Axel Brandes, et al.
Journal of the American Heart Association|November 20, 2023
Heart Failure, Female Sex, and Atrial Fibrillation Are the Main Drivers of Human Atrial Cardiomyopathy: Results From the CATCH ME ConsortiumJoris Winters, Aaron Isaacs, Stef Zeemering, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 2, 2021
Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST - AFNET 4 trialAndreas Metzner, Anna Suling, Axel Brandes, et al.
Pageof 20